![microbe-therapy](https://www.adcreviews.com/wp-content/uploads/2022/12/microbe-therapy-237x160.jpg)
FDA approves first fecal microbe therapy
On November 30, 2022, Ferring Pharmaceuticals announced that its microbiome therapy REBYOTA® (RBX2660) was approved by the FDA, becoming the first approved fecal microbial therapy.
On November 30, 2022, Ferring Pharmaceuticals announced that its microbiome therapy REBYOTA® (RBX2660) was approved by the FDA, becoming the first approved fecal microbial therapy.